THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Clinical trials for THERAPY-RELATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new THERAPY-RELATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for THERAPY-RELATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for tough leukemia
Disease control CompletedThis early-phase study tested a combination of two drugs, pevonedistat and decitabine, in 12 people with high-risk acute myeloid leukemia (AML). The goal was to find the safest dose and see how well the drugs work together to stop cancer cell growth. Participants had AML that was…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 10:39 UTC
-
Tailored therapy boosts hope for older leukemia patients
Disease control CompletedThis study tested a personalized approach to treating acute myeloid leukemia (AML) in adults aged 60 and older. Instead of a one-size-fits-all plan, doctors used genetic tests and a health assessment to choose either standard intensive chemo or a gentler therapy. The goal was to …
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 26, 2026 10:38 UTC
-
New Two-Step transplant shows promise for tough blood cancers
Disease control CompletedThis study tested a two-step stem cell transplant for people with high-risk blood cancers like leukemia and lymphoma. First, patients got low-dose chemotherapy and radiation to prepare the body. Then, they received donor immune cells followed by donor stem cells to help destroy c…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Real-World data on vyxeos liposomal for tough leukemia cases
Knowledge-focused CompletedThis study looked at 113 adults in Italy with certain types of acute myeloid leukemia (AML) who were treated with Vyxeos liposomal as part of their normal care. Researchers tracked how many patients achieved complete remission without signs of leftover disease. The goal was to se…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC